- Seven-decade-old pharma major unveils next-generation website built around AI-powered assistance, faster search and seamless navigation
- New digital platform brings patients, healthcare professionals, global partners and job seekers closer to Cadila’s products, capabilities and opportunities
- Enhanced discovery tools open access to therapeutic portfolios spanning oncology, cardiology, diabetology and gastroenterology
- Revamped “Life at Cadila” portal showcases an innovation-driven workplace while strengthening the company’s global digital presence
NE BUSINESS BUREAU
AHMEDABAD, AUG 21
What does a pharmaceutical company built over seven decades look like when it steps into an AI-first digital world? For Cadila Pharmaceuticals, the answer is a redesigned digital gateway that aims to make finding the right healthcare information almost as easy as asking a question.
Cadila Pharmaceuticals has unveiled a completely revamped, next-generation official website, combining an AI-powered chatbot, enhanced search capabilities and streamlined navigation to create a faster and more intuitive experience for patients, healthcare professionals, global partners and prospective employees.
The new platform has been designed for seamless access across desktops, tablets and smartphones, reflecting the growing importance of digital accessibility in healthcare and pharma.
When AI becomes the new digital front desk
At the heart of the revamped platform is an AI-powered chatbot designed to provide instant assistance and help users locate information on products, services and career opportunities with just a few clicks.
An enhanced search tool and simplified navigation allow visitors to move more efficiently through Cadila Pharmaceuticals’ extensive portfolio, including major therapeutic areas such as Gastroenterology, Oncology, Cardiology and Diabetology, besides its Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organisation (CDMO) partnerships.
The emphasis is clearly on reducing the distance between the user and the information sought—an increasingly important consideration in an era when speed, clarity and accessibility are becoming integral to the digital healthcare experience.
Seven decades of trust, now with a digital accelerator
The transformation comes as Cadila Pharmaceuticals builds on a legacy spanning more than 70 years, while embracing technologies that can reshape how stakeholders interact with the organisation.
Commenting on the digital launch, Jatin Shah, COO, Generics & Institution Business, Cadila Pharmaceuticals Ltd., said, “As we build on our legacy of over seven decades, adapting AI-powered technology into our digital ecosystem reflects our unwavering commitment to healthcare innovation. This revamped platform is thoughtfully designed to make key information accessible, fast, and transparent for all our stakeholders. By leveraging modern digital tools, we continue to reinforce our mission of delivering trusted, high-quality healthcare solutions that improve lives globally.”
The new website consequently seeks to bridge two worlds—Cadila’s established pharmaceutical heritage and the rapidly evolving possibilities of artificial intelligence.
From medicines to meaningful careers
Beyond products and therapeutic areas, the revamped platform also puts Cadila’s R&D capabilities, global footprint and organisational legacy under the digital spotlight.
A strengthened “Life at Cadila” section offers prospective employees a closer look at the company’s workplace culture, with emphasis on innovation, learning and collaboration.
As a Great Place to Work® certified organisation, Cadila has positioned the careers section as a gateway for job seekers looking to explore opportunities and build long-term careers within the pharmaceutical industry.
The new digital platform therefore serves a purpose beyond being an online corporate brochure. It is designed as a single, intelligent interface connecting healthcare information, pharmaceutical capabilities, global partnerships and career opportunities.
For a pharmaceutical enterprise navigating its next chapter, the message is clear: the future of healthcare may be driven by molecules, research and manufacturing—but increasingly, it will also be shaped by how intelligently and effortlessly people can access information about them.
